Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1535 Records) |
| Query Trace: Breast and ovarian cancer [original query] |
|---|
| Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer. JAMA network open 2024 9 7 (9): e2431427. Zoulikha Rezoug, Stephanie P Totten, David Szlachtycz, Adrienne Atayan, Kristen Mohler, Sophie Albert, Leila Feng, Brianna Lemieux Anglin, Zhen Shen, Daniel Jimenez, Nancy Hamel, Nicholas Meti, Khashayar Esfahani, Jean-François Boileau, Ipshita Prakash, Mark Basik, Sarkis Meterissian, Francine Tremblay, David Fleiszer, Dawn Anderson, George Chong, Stephanie M Wong, William D Foulk |
| Screening Familial Risk for Hereditary Breast and Ovarian Cancer. JAMA network open 2024 9 7 (9): e2435901. Daniel Kiser, Gai Elhanan, Alexandre Bolze, Iva Neveux, Karen A Schlauch, William J Metcalf, Elizabeth T Cirulli, Catherine McCarthy, Leslie A Greenberg, Savanna Grime, Jamie M Schnell Blitstein, William Plauth, Joseph J Grzyms |
| Blood molybdenum level as a marker of cancer risk on BRCA1 carriers. Hereditary cancer in clinical practice 2024 9 22 (1): 19. Milena Matuszczak, Adam Kilja?czyk, Wojciech Marciniak, Ró?a Derkacz, Klaudia Stempa, Piotr Baszuk, Marta Bry?kiewicz, Cezary Cybulski, Tadeusz D?bniak, Gronwald Jacek, Tomasz Huzarski, Marcin Lener, Anna Jakubowska, Sandra Pietrzak, Marek Szwiec, Ma?gorzata Stawicka-Nie?acna, Dariusz Godlewski, Artur Prusaczyk, Andrzej Jasiewicz, Tomasz Kluz, Joanna Tomiczek-Szwiec, Ewa Kilar-Kobierzycka, Monika Sio?ek, Renata Posmyk, Joanna Jarkiewicz-Tretyn, Rodney Scott, Steven Narod, Jan Lubi?s |
| Establishing the homologous recombination score threshold in metastatic prostate cancer patients to predict the efficacy of PARP inhibitors. Journal of the National Cancer Center 2024 9 4 (3): 280-287. Diwei Zhao, Anqi Wang, Yuanwei Li, Xinyang Cai, Junliang Zhao, Tianyou Zhang, Yi Zhao, Yu Dong, Fangjian Zhou, Yonghong Li, Jun Wa |
| Mutation Spectrum Comparison between Benign Breast Lesion Cohort, Unselected Cancer Cohort and High-Risk Breast Cancer Cohort. Cancers 2024 9 16 (17): . Ava Kwong, Cecilia Y S Ho, Henry C M Leung, Amy W S Leung, Chun-Hang Au, Edmond S K |
| Predicting BRCA mutation and stratifying targeted therapy response using multimodal learning: a multicenter study. Annals of medicine 2024 9 56 (1): 2399759. Yi Li, Xiaomin Xiong, Xiaohua Liu, Mengke Xu, Boping Yang, Xiaoju Li, Yu Li, Bo Lin, Bo |
| Association of telomerase reverse transcriptase gene rs10069690 variant with cancer risk: an updated meta-analysis. BMC cancer 2024 8 24 (1): 1059. Chao Zhou, Yunke Yang, Lu Shen, Lu Wang, Juan Zhang, Xi |
| The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory. Cancer genomics & proteomics 2024 8 21 (5): 448-463. Nikolaos Tsoulos, Konstantinos Agiannitopoulos, Kevisa Potska, Anastasia Katseli, Christina Ntogka, Georgia Pepe, Dimitra Bouzarelou, Athanasios Papathanasiou, Dimitrios Grigoriadis, Georgios N Tsaousis, Helen Gogas, Theodore Troupis, Konstantinos Papazisis, Ioannis Natsiopoulos, Vassileios Venizelos, Kyriakos Amarantidis, Stylianos Giassas, Christos Papadimitriou, Elena Fountzilas, Maroulio Stathoulopoulou, Anna Koumarianou, Grigorios Xepapadakis, Alexandru Blidaru, Daniela Zob, Oana Voinea, Mustafa Özdo?an, Mahmut Çerkez Ergören, Alinta Hegmane, Eirini Papadopoulou, George Nasioulas, Christos Markopoul |
| The Role of hBRCA2 in the Repair of Spontaneous and UV DNA Damage in Saccharomyces cerevisiae. microPublication biology 2024 8 2024 . Sherrice Law, David Park, Hannah Park, Hannah Zhang, Damon Mey |
| Mayo Clinic Tapestry Study: A Large-Scale Decentralized Whole Exome Sequencing Study for Clinical Practice, Research Discovery, and Genomic Education. Mayo Clinic proceedings 2024 12 . Lorelei A Bandel, Robert A Vierkant, Teresa M Kruisselbrink, Michelle L Bublitz, Tammy A Wilson, Sebastian M Armasu, Jan B Egan, Richard J Presutti, Niloy Jewel J Samadder, Aleksandar Sekulic, Rory J Olson, Jennifer Tan-Arroyo, Joel A Morales-Rosado, Eric W Klee, Matthew J Ferber, Jennifer L Kemppainen, Jennifer L Anderson, Jessa S Bidwell, Joseph J Wick, Victor E Ortega, William V Bobo, Pavel N Pichurin, Jessica M Mcmillan, DeAnna M Weaver, Douglas L Riegert-Johnson, Alanna M Cera, Lauren M Boucher, Iftikhar J Kullo, Sarah K Mantia, Matthew T Jones, Nicholas B Larson, Tony C Luehrs, Jon W Leitzke, Hugues Sicotte, Shulan Tian, Jennifer R Stavlund, Joel E Pacyna, Richard R Sharp, Akwasi A Asabere, James Lu, Tammy M McAllister, T'Nita S Walker, A Keith Stewart, Gianrico Farrugia, Konstantinos N Lazarid |
| Mutation Spectrum Analysis of BRCA1/2 Genes for Hereditary Breast and Ovarian Cancer in the Indian Population. Asian Pacific journal of cancer prevention : APJCP 2024 12 25 (12): 4145-4151. Kunjal Lila, Harshita Bhanushali, MIlind Chanekar, Raj Jatale, Monisha Banerjee, Rakhi Bajpai Dixit, Aparna Rajadhyaksha, Kirti Chad |
| Breast cancer outcomes in women with ovarian cancer and a pathogenic germline BRCA mutation. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2024 12 51 (3): 109380. Quratul Ain, Rachel L O'Connell, Parinita Swarnkar, Terri McVeigh, Angela George, Marios K Tasoulis, Gerald Ph Gui, Jennifer Wiggins, Aadil A Khan, Katherine Dc Krupa, Peter A Barry, Susana Banerjee, Jennifer E Rus |
| Vitamin D binding protein genetic isoforms, serum vitamin D, and cancer risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. PloS one 2024 12 19 (12): e0315252. Stephanie J Weinstein, Dominick Parisi, Alison M Mondul, Tracy M Layne, Jiaqi Huang, Rachael Z Stolzenberg-Solomon, Regina G Ziegler, Mark P Purdue, Wen-Yi Huang, Christian C Abnet, Neal D Freedman, Kai Yu, Demetrius Alban |
| Contribution of large genomic rearrangements in BRCA1/2 genes and CHEK2 1100delC allele variant to the development of breast/ovarian cancer in Argentinian population. Breast cancer research and treatment 2024 12 . Luciana Berlanga, Vanesa Lotersztein, Eliseo I Aranda, Roxana Cerreti |
| Therapy-related myeloid neoplasms in Korean patients with ovarian or primary peritoneal cancer treated with poly(ADP-ribose) polymerase inhibitors. Translational cancer research 2024 12 13 (11): 6018-6027. Yoon Jung Jang, Heyjin Kim, Sang-Young Ryu, Moon-Hong Kim, Beob-Jong Kim, Hee Jung Jung, Jisik Kang, Sung Hyun Yang, Im Il Na, Hyo-Rak Lee, Hye Jin Ka |
| Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background. International journal of molecular sciences 2024 12 25 (23): . Petra Nagy, János Papp, Vince Kornél Grolmusz, Anikó Bozsik, Tímea Pócza, Edit Oláh, Attila Patócs, Henriett Bu |
| Correction to "Mutation spectra of the BRCA1/2 genes in human breast and ovarian cancer and germline". Environmental and molecular mutagenesis 2024 11 65 (6-7): 230. Authors are not available |
| Assessing the impact of contraceptive use on reproductive cancer risk among women of reproductive age-a systematic review. Frontiers in global women's health 2024 11 5 1487820. Shayesteh Jahanfar, Julie Mortazavi, Amy Lapidow, Cassandra Cu, Jude Al Abosy, Kathyrn Morris, Juan Camilo Becerra-Mateus, Meredith Steinfeldt, Olivia Maurer, Jiang Bohang, Paola Andrenacci, Marwa Badawy, Moazzam A |
| AR (CAG) Microsatellite and APEX1 c.444T>G (p.Asp148Glu) Polymorphisms as Independent Prognostic Biomarkers in Prostate Cancer: Insights from an Argentinian Cohort. Cancers 2024 11 16 (22): . Gaston Pascual, Agustina Sabater, Juan Bizzotto, Rocio Seniuk, Pablo Sanchis, Sabrina Ledesma-Bazan, Estefania Labanca, Carlos Scorticati, Osvaldo Mazza, Elba Vazquez, Ayelen Toro, Federico Prada, Geraldine Gueron, Javier Cotigno |
| Pattern Anlysis of Risk-Reducing Strategies in Unaffected Korean BRCA1/2 Mutation Carriers. Current oncology (Toronto, Ont.) 2024 11 31 (11): 6767-6777. Dabin Kim, Jai Min Ryu, Sang-Ah Han, Zisun Kim, Sung-Won K |
| Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients with Gastric Cancer Associated with Hereditary Breast and Ovarian Cancer. Current oncology (Toronto, Ont.) 2024 11 31 (11): 6723-6734. Takuma Hayashi, Kenji Sano, Mako Okada, Manabu Muto, Ikuo Konis |
| The impact of pathogenic BRCA1/2 tumor mutation status on high grade serous epithelial ovarian cancer survival outcome: A multicenter study from Indonesia. SAGE open medicine 2024 11 12 20503121241299849. Sutrisno Sutrisno, Dina Marlina, Kevin Dominique Tjandraprawira, Putri Nadhira Adinda Adriansy |
| Germline Genetic Susceptibility Testing Among Emirati Nationals at Risk for Hereditary Breast and Ovarian Cancer Syndrome. JCO global oncology 2024 11 10 e2400352. Rifaat R Rawashdeh, Holly Pederson, Rafal Iskanderian, Fawad Khan, Basel Altrabulsi, Stephanie Ricci, Charis Eng, Bassel Jallad, Asma Ibrahim Al Mannaei, Mohamed Salem Alameri, Azza Attia, Stephen R Grobmy |
| PALB2 analysis in the diagnostic process of breast cancer: An Italian monocentric experience. Tumori 2024 10 3008916241290738. Maria Grazia Tibiletti, Ileana Carnevali, Sofia Facchi, Laura Libera, Corrado Chiappa, Fausto Sessa, Stefano La Rosa, Francesca Rove |
| Two founder variants account for over 90% of pathogenic BRCA alleles in the Orkney and Shetland Isles in Scotland. European journal of human genetics : EJHG 2024 10 . Shona M Kerr, Lucija Klaric, Marisa D Muckian, Emma Cowan, Lesley Snadden, Gannie Tzoneva, Alan R Shuldiner, Zosia Miedzybrodzka, James F Wils |
| Homologous recombination deficiency gene panel analysis results in synchronous endometrial and ovarian cancers. Revista da Associacao Medica Brasileira (1992) 2024 10 70 (10): e20240534. Ferah Kazanci, Zerrin Y?lmaz Çelik, Mert Polat, Ferhat Karademir, Ozlem Erdem, Feride ?ffet ?ahin, Mehmet Anil On |
| Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese organization of hereditary breast and ovarian cancer registry data. Breast cancer research and treatment 2024 10 . Nana Komatsu, Takashi Chishima, Chie Watanabe, Kanae Taruno, Mayuko Inuzuka, Masanori Oshi, Masami Arai, Seigo Nakamu |
| Prevalence and outcomes of germline pathogenic variants of homologous recombination repair genes in ovarian cancer. Cancer science 2024 10 . Maiko Miwa, Masakazu Kitagawa, Yuka Asami, Mayumi Kobayashi-Kato, Takafumi Watanabe, Aiko Ogasawara, Kengo Hiranuma, Hisamori Kato, Motonobu Saito, Yohei Miyagi, Tomoyasu Kato, Hiroshi Yoshida, Yukihide Momozawa, Takashi Kohno, Kouya Shiraishi, Kosei Hasega |
| Percentage of fat in milk consumption and risk of six cancers: a Mendelian randomization study. Translational cancer research 2025 1 13 (12): 6613-6622. Tongtong Bai, Chengyu |
| Los olvidados: Non-BRCA variants associated with Hereditary breast cancer in Mexican population. Breast cancer research : BCR 2025 1 27 (1): 7. Dione Aguilar, María Lourdes Garza-Rodríguez, Carolina Elizabeth Muñiz-Garza, Fernando Alcorta Nuñez, Cynthia Mayte Villarreal-Garza, Oscar Vidal-Gutiérrez, Diana Cristina Pérez-Ibave, Carlos Horacio Burciaga-Flor |
- Page last reviewed:Feb 1, 2024
- Content source: